Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.

Abstract

OBJECTIVES To evaluate levetiracetam (LEV) tolerability in patients with epilepsy and liver disease. METHODS Fourteen patients with epilepsy and concomitant liver disease were treated with LEV in an open prospective investigation mimicking the daily clinical practice. All patients were stabilized (ie, for at least 1 year) on traditional antiepileptic… (More)
DOI: 10.1097/WNF.0b013e31815c1d92

Topics

  • Presentations referencing similar topics